WallStSmart
PRFX

Painreform Ltd

NASDAQ: PRFX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.88
-7.84% today

Updated 2026-04-29

Market cap
$1.72M
P/E ratio
—
P/S ratio
101.35x
EPS (TTM)
$-7.47
Dividend yield
—
52W range
$2 – $12
Volume
0.6M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Painreform Ltd (PRFX) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item201720182019202020212022202320242025
Revenue—$0.00$0.00$0.00$0.00$86000.00$0.00$0.00$17000.00
Revenue growth (YoY)——————-100.0%——
Cost of revenue——$1000.00—$7000.00$15000.00$15000.00$16000.00$844000.00
Gross profit——$-1000.00—$-7000.00$71000.00$-15000.00$-16000.00$-827000.00
Gross margin—————82.6%——-4864.7%
R&D$504000.00$223000.00$136000.00$354000.00$2.86M$4.42M$6.04M$11.71M$1.14M
SG&A$376000.00$277000.00$553000.00$1.32M$4.35M$4.45M$3.48M$2.97M$3.17M
Operating income$-880000.00$-500000.00$-689000.00$-1.67M$-7.21M$-8.87M$-9.58M$-14.67M$-4.99M
Operating margin—————-10312.8%——-29335.3%
EBITDA$-1.21M$-501000.00$-688000.00$-1.67M$-7.20M$-8.76M$-9.57M$-14.55M$-4.21M
EBITDA margin—————-10180.2%——-24782.4%
EBIT$-2.09M$-497000.00$-689000.00$-1.67M$-7.21M$-8.77M$-9.58M$-14.57M$-4.99M
Interest expense$0.00$324000.00$541000.00$987000.00$10000.00$61000.00$384000.00$14000.00$10000.00
Income tax—————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.09M$-828000.00$-1.82M$-4.05M$-7.25M$-8.79M$-9.34M$-14.59M$-4.84M
Net income growth (YoY)—+60.4%-119.8%-122.7%-78.8%-21.3%-6.3%-56.1%+66.8%
Profit margin—————-10223.3%——-28458.8%